Grants per year
Personal profile
Research Interests
Dr. Ma' clinical and research interests are focused on chronic lymphoid malignancies,including chronic lymphocytic leukemia and non-Hodgkin lymphoma. Dr. Ma directs the clinical and translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translational investigations have included novel biologic agents, mechanisms of drug resistance and immunotherapy. Dr. Ma is the Principal Investigator for a number of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for CLL and lymphoma. She collaborates with investigators at Northwestern University, other US institutions and international institutions in developing novel therapeutic approaches in hematologic malignancies.
Certifications and Licenses
| Medical Oncology | |
| Hematology | |
| Internal Medicine |
Training Experience
| 2005 | Residency, Resurrection Hospitals |
| 2008 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Northwestern University
… → 2000
MD, Medicine, Beijing Medical University
… → 1994
Research interests keywords
- Biologic Therapies
- Blood Cancer (leukemia and lymphomas)
- Chronic Lymphocytic Leukemia
- Hematology
- Non-Hodgkin's Lymphoma
- Oncology
Fingerprint
Dive into the research topics where Shuo Ma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #BGB-11417-203: An Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of the BCL2 Inhibitor Sonrotoclax (BGB-11417) as Monotherapy and in Combination with Zanubrutinib (BGB-3111) in Patients With Waldenström Macroglobulinemia
Ma, S. (PD/PI)
9/27/24 → 9/27/27
Project: Research project
-
Prot #M23-647: First-in-Human Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of the BTK Degrader, ABBV-101, in Participants with B-cell Malignancies
Ma, S. (PD/PI)
5/28/24 → 5/28/27
Project: Research project
-
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Karmali, R., Galvez, C., Hamadani, M., Gordon, L., Winter, J., Ma, S., Nelson, V., Fenske, T. S., Shah, N. N., Jagadeesh, D., Klein, A., Helenowski, I., Chen, R., Mi, X., Petrich, A., Evens, A. M. & Pro, B., Apr 9 2024, In: Blood Advances. 8, 7, p. 1612-1620 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
B-ALL in a 21-year-old male with X-linked agammaglobulinemia (XLA): a case report and review of B-cell malignancies in XLA
Franco, S., Fuchs, J., Dinner, S. & Ma, S., 2024, (Accepted/In press) In: Leukemia and Lymphoma.Research output: Contribution to journal › Letter › peer-review
-
Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2024
Wierda, W. G., Brown, J., Abramson, J. S., Awan, F., Bilgrami, S. F., Bociek, G., Brander, D., Cortese, M., Cripe, L., Davis, R. S., Eradat, H., Fakhri, B., Fletcher, C. D., Gaballa, S., Hamid, M. S., Hill, B., Kaesberg, P., Kahl, B., Kamdar, M. & Kipps, T. J. & 16 others, , Apr 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 3Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Correction to: “Accelerated” chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): unraveling the biological gray zone of CLL/SLL in the era of novel therapies (Virchows Archiv, (2024), 10.1007/s00428-024-03920-7)
Vadasz, B., Zak, T., Aldinger, J., Sukhanova, M., Gao, J., Wolniak, K. L., Chen, Y. H., Chen, Q. C., Ma, S. & Tariq, H., 2024, (Accepted/In press) In: Virchows Archiv.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
Karmali, R., Machhi, R., Epperla, N., Shouse, G., Romancik, J., Moyo, T. K., Kenkre, V., Ollila, T. A., Fitzgerald, L., Hess, B., David, K., Roy, I., Zurko, J., Chowdhury, S. M., Annunzio, K., Ferdman, R., Bhansali, R. S., Harris, E. I., Liu, J. & Nizamuddin, I. & 11 others, , May 28 2024, In: Blood Advances. 8, 10, p. 2592-2599 8 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations